Skip to main content

What the FDA labels say about taking them together

Lidocaine and propafenone

Propafenone's FDA label of September 1, 2025 names lidocaine in its drug interactions section; the lidocaine labels PlainMeds reads (4) do not name propafenone. The propafenone label: “Taper orlistat withdrawal. Lidocaine may increase central nervous system side effects.”

Check it at the source: the lidocaine FDA label on DailyMed (effective May 13, 2024, Fresenius Kabi USA, LLC); the propafenone FDA label on DailyMed (effective September 1, 2025, Strides Pharma Science Limited).

What does the lidocaine label say about propafenone?

Lidocaine's label (effective May 13, 2024) and its 3 other brand-application labels do not name propafenone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Xylocaine MPF), Fresenius Kabi USA, LLC, effective May 13, 2024 (SPL set d5e0d06f-ba1e-44d4-aa89-39d6c146dc23), via openFDA; the full label on DailyMed

What does the propafenone label say about lidocaine?

Propafenone label, drug interactions

Taper orlistat withdrawal. (7.4) Lidocaine may increase central nervous system side effects.

Source: FDA drug label (PROPAFENONE HYDROCHLORIDE), Strides Pharma Science Limited, effective September 1, 2025 (SPL set c65253ab-937f-4982-b841-69c2b9f9ccdb), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

81Lidocaine generic labelers
14Propafenone generic labelers
LidocainePropafenone
Labeled forPainAtrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)$0.154 per gram 5% ointment$0.115 per tablet 150 mg tablet
Shortage nowIn shortageNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?